Bosh sahifaOGN • NYSE
add
Organon & Co
Yopilish kursi
11,05 $
Kunlik diapazon
10,86 $ - 11,21 $
Yillik diapazon
10,86 $ - 23,10 $
Bozor kapitalizatsiyasi
2,82 mlrd USD
Oʻrtacha hajm
4,19 mln
Narx/foyda
3,26
Dividend daromadliligi
10,31%
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,59 mlrd | -0,38% |
Joriy xarajat | 598,00 mln | 14,78% |
Sof foyda | 109,00 mln | -80,04% |
Sof foyda marjasi | 6,85 | -79,95% |
Har bir ulushga tushum | 0,90 | 2,27% |
EBITDA | 375,00 mln | -17,40% |
Amaldagi soliq stavkasi | 15,50% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 675,00 mln | -2,60% |
Jami aktivlari | 13,10 mlrd | 8,65% |
Jami passivlari | 12,63 mlrd | 4,13% |
Umumiy kapital | 472,00 mln | — |
Tarqatilgan aksiyalar | 257,95 mln | — |
Narxi/balansdagi bahosi | 6,04 | — |
Aktivlardan daromad | 5,76% | — |
Kapitaldan daromad | 7,95% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 109,00 mln | -80,04% |
Operatsiyalardan naqd pul | 390,00 mln | -1,76% |
Sarmoyadan naqd pul | -296,00 mln | -265,43% |
Moliyadan naqd pul | -82,00 mln | -6,49% |
Naqd pulning sof oʻzgarishi | -88,00 mln | -131,54% |
Boʻsh pul | 268,75 mln | -27,88% |
Haqida
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Tashkil etilgan
1923
Sayt
Xodimlar soni
10 000
